Spdr Sp Biotech Etf Fundamentals

XBI Etf  USD 83.48  1.17  1.38%   
SPDR SP Biotech fundamentals help investors to digest information that contributes to SPDR SP's financial success or failures. It also enables traders to predict the movement of SPDR Etf. The fundamental analysis module provides a way to measure SPDR SP's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SPDR SP etf.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

SPDR SP Biotech ETF Price To Earning Analysis

SPDR SP's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current SPDR SP Price To Earning

    
  19.71 X  
Most of SPDR SP's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SPDR SP Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, SPDR SP Biotech has a Price To Earning of 19.71 times. This is 189.85% higher than that of the SPDR State Street Global Advisors family and significantly higher than that of the Health category. The price to earning for all United States etfs is notably lower than that of the firm.

SPDR SP Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining SPDR SP's current stock value. Our valuation model uses many indicators to compare SPDR SP value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SPDR SP competition to find correlations between indicators driving SPDR SP's intrinsic value. More Info.
SPDR SP Biotech is rated first in price to earning as compared to similar ETFs. It is rated first in price to book as compared to similar ETFs fabricating about  0.13  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for SPDR SP Biotech is roughly  7.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value SPDR SP by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for SPDR SP's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SPDR SP's earnings, one of the primary drivers of an investment's value.

SPDR Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SPDR SP's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of SPDR SP could also be used in its relative valuation, which is a method of valuing SPDR SP by comparing valuation metrics of similar companies.
SPDR SP is currently under evaluation in price to earning as compared to similar ETFs.

Fund Asset Allocation for SPDR SP

The fund invests 99.97% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
Asset allocation divides SPDR SP's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.

SPDR Fundamentals

About SPDR SP Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze SPDR SP Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SPDR SP using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SPDR SP Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States.

SPDR SP Implied Volatility

    
  116.14  
SPDR SP's implied volatility exposes the market's sentiment of SPDR SP Biotech stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if SPDR SP's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that SPDR SP stock will not fluctuate a lot when SPDR SP's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards SPDR SP in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, SPDR SP's short interest history, or implied volatility extrapolated from SPDR SP options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:
Check out SPDR SP Piotroski F Score and SPDR SP Altman Z Score analysis.
Note that the SPDR SP Biotech information on this page should be used as a complementary analysis to other SPDR SP's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.